← Leaderboards
Daniel T O'Connor
University Of California San Diego
$5,574,664
Attributed
$5,574,664
Total exposure
13
Grants
10
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $3.2M · FY2005–13$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
Funding mix
By agency
NIH$36,125,624 · 15
By mechanism
P01$21,066,588 · 4
U01$12,793,800 · 3
R01$2,132,898 · 2
M01$115,845 · 4
R13$15,500 · 1
P41$993 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of California San Diego
Same institution · by research overlap
- Laurent Taupenot$1,672,200
- Sucheta M Vaingankar$2,726,093
- Vivian Y. H. Hook$23,603,887
- Peter E Cadman$243,540
Others in their field
Top investigators on “Blood Pressure”
- David R. Weir · University Of Michigan At Ann Arbor$96,362,652
- Michael A Province · Washington University$60,417,406
- Leonardo Trasande · New York University School Of Medicine$55,277,738
- Rohit Varma · University Of Southern California$55,238,158
- Eric A Boerwinkle · University Of Texas Hlth Sci Ctr Houston$54,376,013
- Jiang He · Tulane University Of Louisiana$45,164,948
Research focus
Blood PressureGenetic PolymorphismHuman SubjectCooperative StudyCatecholaminesHypertensionPharmacogeneticsClinical ResearchGeneticPhenotypeGenotypeBlood CirculationChromograninsSympathetic Nervous SystemVariantBaseSeriesGenomicsGenesBlood VesselsPhysiologyMediatingNeurotransmitter TransportBiochemical
Grant awards (52)
Hypertensive kidney disease: Novel pathogenic and therapeutic pathway$373,475
R01 · FY2013 · DK · contact PI
Hypertensive kidney disease: Novel pathogenic and therapeutic pathway$336,853
R01 · FY2012 · DK · contact PI
Hypertensive kidney disease: Novel pathogenic and therapeutic pathway$43,657
R01 · FY2012 · DK · contact PI
10th International Catecholamine Symposium (XICS)$15,500
R13 · FY2012 · DA · contact PI
PHARMACOGENETICS$5,868
M01 · FY2010 · RR · contact PI
Sympathetic Neuroeffector Junctions & Blood Pressure$2,389,302
P01 · FY2009 · HL · contact PI
Core--Human phenotyping$241,145
P01 · FY2009 · HL · contact PI
Novel catecholamine release-inhibitory peptide$241,144
P01 · FY2009 · HL · contact PI
Sympathetic Neuroeffector Junctions & Blood Pressure$22,143
P01 · FY2009 · HL · contact PI
PHARMACOGENETICS$1,133
M01 · FY2009 · RR · contact PI
Sympathetic Neuroeffector Junctions & Blood Pressure$2,221,426
P01 · FY2008 · HL · contact PI
Novel catecholamine release-inhibitory peptide$297,924
P01 · FY2008 · HL · contact PI
Core--Human phenotyping$190,350
P01 · FY2008 · HL · contact PI
Sympathetic Neuroeffector Junctions & Blood Pressure$2,209,280
P01 · FY2007 · HL · contact PI
Novel catecholamine release-inhibitory peptide$313,589
P01 · FY2007 · HL · contact PI
Core--Human phenotyping$199,300
P01 · FY2007 · HL · contact PI
PHARMACOGENETICS$9,302
M01 · FY2007 · RR · contact PI
CHROMAGRANIN A COILED-COIL STRUCTURE$993
P41 · FY2007 · RR · contact PI
Sympathetic Neuroeffector Junctions & Blood Pressure$2,217,254
P01 · FY2006 · HL · contact PI
Novel catecholamine release-inhibitory peptide$301,066
P01 · FY2006 · HL · contact PI
Sympathetic Outflow to Catecholamine Storage Vesicles$275,704
R01 · FY2006 · DK · contact PI
Core--Human phenotyping$190,318
P01 · FY2006 · HL · contact PI
PHARMACOGENETICS$31,533
M01 · FY2006 · RR · contact PI
Sympathetic Neuroeffector Junctions &Blood Pressure$2,225,124
P01 · FY2005 · HL
Novel catecholamine release-inhibitory peptide$292,521
P01 · FY2005 · HL
Sympathetic Outflow to Catecholamine Storage Vesicles$282,340
R01 · FY2005 · DK
Core--Human phenotyping$184,750
P01 · FY2005 · HL
Administration$146,260
P01 · FY2005 · HL
PHARMACOGENETICS$39,685
M01 · FY2005 · RR
Autonomic Pharmacodynamic Pharmacogenomics$2,986,871
U01 · FY2004 · HL
Sympathetic Outflow to Catecholamine Storage Vesicles$282,340
R01 · FY2004 · DK
Pharmacogenetics$28,324
M01 · FY2004 · RR
Autonomic Pharmacodynamic Pharmacogenomics$2,933,291
U01 · FY2003 · HL
SYMPATHETIC NEUROEFFECTOR JUNCTIONS AND BLOOD PRESSURE$1,877,389
P01 · FY2003 · HL
Sympathetic Outflow to Catecholamine Storage Vesicles$261,350
R01 · FY2003 · DK
Autonomic Pharmacodynamic Pharmacogenomics$2,867,651
U01 · FY2002 · HL
SYMPATHETIC NEUROEFFECTOR JUNCTIONS AND BLOOD PRESSURE$1,449,646
P01 · FY2002 · HL
SYMPATHETIC NEUROEFFECTOR JUNCTIONS AND BLOOD PRESSURE$380,240
P01 · FY2002 · HL
Phenotyping--genetic determinants of presynaptic adrenergic mechanisms$318,627
U01 · FY2002 · HL
Sympathetic Outflow to Catecholamine Storage Vesicles$277,179
R01 · FY2002 · DK
Autonomic Pharmacodynamic Pharmacogenomics$254,618
U01 · FY2002 · HL
AFRICAN AMERICAN STUDY OF KIDNEY DISEASE$68,366
U01 · FY2002 · DK
Phenotyping--genetic determinants of presynaptic adrenergic mechanisms$0
U01 · FY2002 · HL
Autonomic Pharmacodynamic Pharmacogenomics$2,882,325
U01 · FY2001 · HL
SYMPATHETIC NEUROEFFECTOR JUNCTIONS AND BLOOD PRESSURE$1,714,097
P01 · FY2001 · HL
Autonomic Pharmacodynamic Pharmacogenomics$157,983
U01 · FY2001 · HL
Phenotyping--genetic determinants of presynaptic adrenergic mechanisms$0
U01 · FY2001 · HL
Phenotyping--genetic determinants of presynaptic adrenergic mechanisms$0
U01 · FY2001 · HL
SYMPATHETIC NEUROEFFECTOR JUNCTIONS AND BLOOD PRESSURE$1,762,320
P01 · FY2000 · HL
AFRICAN AMERICAN STUDY OF KIDNEY DISEASE$208,148
U01 · FY2000 · DK
AFRICAN AMERICAN STUDY OF KIDNEY DISEASE$57,960
U01 · FY2000 · DK
AFRICAN AMERICAN STUDY OF KIDNEY DISEASE$57,960
U01 · FY2000 · DK